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SUMMARY.-The pathological features, particularly local extent, size, and
nodal involvement, of 405 surgical specimens of human lung carcinomas were
studied. A direct relationship was found between local extent and size of the
tumour and between local extent and the incidence of lymph node metastasis,
but not between tumour size and the incidence oflymph node metastasis. The
survival rates in the 405 tumours were calculated with the actuarial method in
relation to the 3 pathological factors: local extent, lymph node metastasis and
tumour size showed a predictive value in prognosis of lung tumours. Their
prognostic value, however, was much more meaningful when the three patho-
logical factors were considered in relation to each other. As a matter of fact,
the size of the tumour showed no predictive value when lymph node metastasis
was present. On the ground of the mutual influence of the 3 factors inaffecting
prognosis a pathological stage-grouping of lung tumours has been suggested.
ATTEMPTS to find clinical as well aspathological factorsbearing on theprognosis
oflung tumours have been for the most part unrewarding (Watson, 1968; Bennet
etal., 1969). Generalagreement has been reached on thepredictive value ofnodal
involvement, which lowers significantly the survival rate (Nohl, 1960; Hukfll and
Stern, 1962; Bergh and Sherste'n, 1965; Nagaishi and Okada, 1968; Goldberg
et al., 1970). The value of other pathological factors like size of the tumour,
pleural and/or vascular involvement, histological type, site and/or location of the
tumour (Collier et al., 1958; Spjut et al., 1961; Maamies, 1966; Schottenfield,
1968; Jackman et al., 1969; Bennet et al., 1969; Slack, 1970) has been emphasized
by some authors anddeniedby others.
Higgins and Beebe (1967) found that only 4 or 5 out of 40 both clinical and
pathological factors examined carried independent information predictive of
cancer-free survival at 36 or 60 months. Midorikawa et al. (1968) found that it
was difficult to predict the prognosis of resected lung tumours on the basis of
pathological examination.
Thisdisagreement can be inpartexplained by the limitations ofroutine patho-
logical examination (Sherwin, 1966) and more generally with the rather rough definition of some ofthe studied factors. A secondpoint which seems worthwhile
considering is that most of these factors have generally been taken into account
one at a time. Some factors maylikelyplay a different role in affectingprognosis whetherthey are or are not related to other factors.
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In a recent paper(Campobasso etal., 1970) we tried togive a clear-cut definition
of local extent of lung tumours taking into account the site of the tumour, the
involvement of main blood vessels, and the spread to contiguous or neighbouring
structures such as visceral or parietal pleura, main bronchus, chest wall, etc.
(excluding lymph nodes). Tumours were subdivided into 4 categories of local
extent, denoted by the symbol P--degrees ofhistopathological extent, according
to the term suggested by the Union Internationale Contre le Cancer (UICC, 1969).
The main aim ofthis classification was to supply a basis for an accurate recording
of the extent oflung tumours.
It is the purpose of this present paper to evaluate the relationship of local
extent with 2 other factors in survival, i.e., size of the tumour and nodal involve-
ment and to establish thesignificance ofthese 3pathologicalfactors,independently
and when considered in relation to each other. The histological type will not be
taken into account; it will be discussed in a future paper.
MATERIAL AND METHODS
Five hundred and forty-six surgical specimens of lung carcinomas, obtained
from the Thoracic Surgery Centre of the University ofTurin, up to the December
31) 1965, have been studied. All the available data for these patients have been
reported on marginal punch cards. One hundred and forty-one cases were
excluded from the series: 33 for lack ofinformation about survival; 30 because the
pathological recording was not sufficient for an accurate classification; 7 because
the bronchopulmonary origin of the tumour was doubtful; 71 because of post-
operative death (I month). As previously stated histological type has not been
taken into account inthisstudy. However, allthe tumoursincludedinthepresent
series were frank invasive carcinomas. Carcinoids, mucous-gland tumours,
bronchial papillomata, lymphomas and other rare tumours were excluded.
The present series includes 405 cases for which sufficient clinical andpathologi-
cal data were available. For the present study the following data have been
taken into account:
(a) the category of local extent (P) (Campobasso et al., 1970). Lung tumours
have been subdivided into 4 categories of local extent as follows: PI, central or
peripheral tumours confined to thelung; P2, tumoursinvolving the main bronchus
or the visceral pleura, excluding the pleura lining the fissures; P3, tumours with
spread to mediastinal soft tissues and/or other mediastinal structures (excluding
lymph iiodes) such as pericardium and main blood vessels, or to parietal pleur,a
and chest wall including diaphragm; P4, tumours with 2 or more separate neo-
plastic masses in the same lobe or in different lobes ofthe samelung.
(b) the size of the tumour. Tumours have been subdivided into tumours up
to 4 cm. in diameter and tumours larger than 4 cm. in diameter. This arbitrary
limit has been chosen because it has been adopted by other authors (O'Connor
et al., 1963; Bennet et al., 1969; Jackman et al., 1969). The size was taken into
account in 379 tumours only, excluding multiple tumours (P4 tumours, 26 cases)
where it would have been difficult and perhaps useless to measure the size of the
whole neoplastic tissue.
(c) the involvement ofregional lymph nodes. This has been checked macro-
scopically and microscopically. One to 6 lymph nodes have been examined for
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suspicious; moreover only in a certain number of cases data on the exact site of
the resectedlymph nodes were available. So the presence oflymph node metasta-
sis (indicated with N+) signifies that I or more lymph nodes, regardless of their
site and number, were involved by the tumour, while absence of metastasis
(indicated with N-) signifies that in none of the examined lymph nodes were
neoplastic cells present.
(d) the data on the survival. At the Thoracic Surgery Centre oftheUniversity
ofTurin, people from everyregion ofItaly are admitted. This made itimpossible
to re-examine directly all the patients who had been operated on, months or years
before. In many cases information on the course of the disease was obtained by
letters from patients themselves or from their relatives, so that it has not been
possible to take into account thepossible presence of recurrences at the moment of
the follow-up or the causes ofdeath, as well as the data on post-operativetherapy.
Consequently, people alive at the moment of the last control have been regarded
as survivors irrespective of the presence of recurrences. Dead people were
regarded as being so due to their lung tumours. However, when known, the
cause of death was clearly referable to the tumour. Of the 405 patients included
in thepresent series, 404 werefollowed-up for more than 2 years, 369 for more than
3 years, and 298 for 5 years or more.
The survival rates have been calculated by the actuarial method of Berkson
and Gage (1950). The 95% confidence limits of survival rates and the statistical
significance ofthe observed differences have been calculated applying the formula
of Greenwood quoted by Denoix (1969); a further control of the statistical signifi-
cance has been made with Fischer's exact probability method comparing the
absolute values instead of the corresponding percentages. The significance level
has been chosen at 5% (P < 0-05).
RESULTS
Out of 405 tumours, 223 (55-1%) were classified as Pl, 111 (27-4%) as P2,
45 (11-1%) as P3 and 26 (6-4%) as P4. The incidence oflymph node metastasis
was 30-3% in the whole series, ranging from 30-6% to 69-2% in the 4 P categories
(Table 1). The percentage of tumours up to 4 cm. in diameter ranged from 43%
in P1 category to 16
-2% in P2 category. The difference in the incidence oflymph
node metastasis between PI and P2 on one side and P3 and P4 on the other side
was statistically significant. The incidence of small tumours in PI was signifi-
cantly lower than in P2 and P3. There was practically no difference in the inci-
dence oflymph node metastasis between small and large tumours (Table II).
In the whole series the survival rates at 2 years, 3 years and 5 years were
36-5%, 30-7% and 23-5% respectively (Table III).
Table IIIreports also the survival ratesaccording to P. These rates decreased
inversely to the local extent and wereextremely low in P4 tumours; the difference
in survival between PI and any other P category was statistically significant
the survival rate wasnearly the same at any time in P2 and P3 tumours.
Tables IV and V show the survival rates according to nodal involvement and
size of the tumour respectively. The differences in survival were statistically
significant at 2, 3 and 5 years for both N- versus N+ tumours (P < 0-01) and
small versus large tumours (P < 0-001).
The survival patterns by P category and lymph node metastasis, and bv P
category and size, are shown in Fig. I and 2 respectively.Nodal involvement
r I
N N +
A
r
No. % No. %
143 64-1 80 35-9 .
77 69
-4 34 30- 6 .
18 40-0 27 60- 0 .
8 30- 8 18 69
- 2 .
TABLEIII.-Survival Rate,8in 405 Re8eCted Lung Tumour8According to
P Category
Survival rate at
I A
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TABLEL-Relationship Between P and N and P and Size
Tumour size
r
< 4cm. > 4 cm.
A
No. % No.
%
96 43- 0 127 57-0
18 16-2 93 83- 8
11 24-5 34 75-5
p
category
Pi
P2
P3
P4
No.
223
ill
45
26
* Size has not been taken into account in P4 tumours.
TABLE II.-Relationship Between Size and N (Excluding P4 Tumours)
Nodal involvement
t A
I
N N +
A
r (
No. % No. %
81 64- 8 44 35-2
157 61-8 97 38-2
Tumour
size No.
< 4 cm. 125
> 4 cm. 254
p
category
Pi
P2
P3
P4
Total
2 years
49-26±7
26- 13±8
17-78±11
3-85±8
36-53±5
3 years
42
-70±7
19-59±8
15-56±11
30-71±4
6 years
33-89±7
12-74±6
11.11±9
27-47±4
No.
223
III
45
26
405
TABLEIV.-Survival Rate8 in 405 Re8ected Lung Tumours According to
Nodal Involvement
Survival rate at
A
I'
2 years 3 years 5 years
46-34+6 38-37±6 29-32±6
21-21±6 18-52±6 13-84±6
Nodal
involvement
N-
N+
No.
246
156
TABLE V.-Survival Rates in 379 Resected Lung Tumours According to Tumour
Size (Excluding P4 Tumours)
Survival rate at
Tumour 2 years 3 years 5 yeaxs
size No. % % %
< 4 cm. 125 53-604-9 46-90±9 38-20±9
> 4 cm. 254 31-42±6 25-71±6 18-36+5Survival rate at
A
I
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TABLEVI.-Survival Ratmin 379 Resected Lung Tumours According to N
and Size*
Tumour
Nodal
involvement
N-
size 2 years
(cm.) No. %
<4 81 - 65-43±11
>4 157 - 38-85±8
<4 44 - 31-82±14
>4 97 . 19-28±8
3 years
56-54±11
30-95±7
29-27±14
17-14±8
5 years
48-07±11
21-12±7
19-32±13
13-69±7
* P4 tumours have not been taken into account.
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FIG. I.-Survival by P category in N (a) and N+ (b) tumours.
Table VI shows the survival rates according to size in N- and N+ tumours, regardless of P category. The difference in survival between small and large tumours at 2 years, 3 years, and 5 years was statistically significant (P < 0-01 at
any interval) in N- tumours only. The difference was much less evident and
statistically not significant at any interval in N+ tumours.
Table VII shows the survival rates in the 405 resectedlung tumours subdivided
by category of local extent (P) and according to nodal involvement (N) and size.A
5 years
55- 11±13
30-92±11
24-13±15
19-28±12
31-254-23
8-12±7
12-50±12
33-33±38
16-67±22
4-55+9
f..
2 years
66-10±12
53-57±11
35-16±16
29-66±15
75-00±22
21-31±10
12-50±12
33
-33±38
25-00±25
20-00±36
9
-09±12
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TABLEVII.-Survival Rates in 405 Re8eCted Lung Tumour8According to P,
N and Size
Survival rate at
3 years
59-05±13
45-05±11
32-15+15
24-72±13
56-25±25
14-21±9
12-50+12
33-33±38
16-67±22
20-00±36
9-09±12
p
category
Pi
Nodal
involvement
N-
N+
Size
(cm.)
<4
>4
<4
> 4
<4
> 4
<4
> 4
< 4
> 4
<4
> 4
No.
59
84
37
43
16
61
2
32
6
12
5
22
P2 N-
N+
P3 N-
N+
P4 N-
N+
8 .
18 - 5-56±11
* Size has not been taken into account in P4 tumours.
Pi
P2
P3
Pi
P2
P3
FiG. 2.-Survival by P category in tumours up to 4 cm. in diameter (a) and larger than 4 cm. (b).675 FACTORS IN SURVIVAL OF LUNG TUMOURS
PI N- tumours up to 4 cm. in diameteryielded the highest 5 years survival rate
(55-1%). PI N- tumours larger than 4 cm. and both P2 N- and P3 N
tumours up to 4 cm. showed intermediatefigures (more than 30% alive at 5years).
P2 N- and P3 N- large tumours, as well as N+ tumours yielded a rather poor
survival (less than 25% alive at 5 years). In P4 tumours the size was not taken
into account and the survival was very poor for both N- and N+ lesions.
DISCUSSION
Most of the tumours in the present series were confined to the lung
(223 == 55-1%) and/or had not spread to lymph nodes (246 60-7%). This
is not surprising in a surgical series and it is clearly understood that these figures
may not be related to lung tumours in general. At the Thoracic Surgery Centre
ofTurin theresectability rate forlung cancer was found to be 29% (Masenti et al.,
1969). As the resectability is in the main directly related to the spread of the
tumour, this means that only a small proportion of the lung tumours seen at the
Thoracic Surgery Centre of Turin up to December 31, 1965 were confined to the
lung and had not spread to lymph nodes when first diagnosed.
The 5 years survival rate in the whole series of 405 resected cases was 23-37%,
similar to thatreportedby many authors (Collier etal., 1957; Bergh andScherste'n,
1965; Maamies, 1966; Watson, 1968; Kern etal., 1968; Slack, 1970).
All the 3pathological factors taken into account, when examined one at a time
(Tables 111, IV andV), carried significant informationpredictive ofpost-operative
survival. Apparently the size of the tumour was the most important factor in
survival as at 5 years, when examinedindependently from the other factors, small
tumoursyielded the highest survival rate (38-20%), following tumours confined to
the lung (PI, 33-89%), and tumours without nodal involvement (N-, 29-32%).
When theirrelationships were considered, however, a complicated but meaningful
pattern of associations and mutual influences was detected among these factors.
The somewhat different meaning and importance ofthe various factors considered
in conjunction with one another need some comment.
As for the local extent there was a direct relationship betweeii P category and
both the incidence of node metastasis and the size of the tumour (Table 1). The
lower incidence of node metastasis in more locally extended tumours is in agree-
ment with the findings ofNohl (1960), who classified lung tumours in 3 categories
of local extent, A, B, and C, roughly corresponding to our PI to P3 categories.
In the present series however, the predictive value of local extent was rather
independent of the incidence of node metastasis in the different P categories; in
fact both N- and N+ tumours (Fig. la, b) showed a survival pattern by P
category very similar to that of the whole series (Table 111), showing a marked
difference between PI and P2 and approximately the same survival rates in P2
and P3 categories. The influence oflymph node metastasis was only in that the
difference between PI and the other P categories as a whole was statistically
significant at any interval inN-tumours(P < 0
-01) butonlyat 2yearsand 3years
in N+ tumours (P < 0-05). In P2 category the incidence oflymph node metas-
tasis was somewhat lower than in Pl. The very high percentage oflarge lesions
(83-8%, Table 1) among P2 tumours may partly account for their poor prognosis.
In small tumours indeed there was some overlapping in survival between Pl and
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-between P2 and P3 tumours at 2 years (Fig. 2a). Inlarge tumours (Fig. 2b) the
survival pattern by P category was quite consistent with that of the whole series
(Table 111). Neither the nodal involvement nor the tumour size, however, were
useful for a clear cut difference in prognosis between P2 and P3 tumours. The
lack of difference between these 2 categories is not in agreement with the findings
of Nohl (1960) and of Bergh and Scherste'n (1965). The latter authors found a
marked difference between their A and B groups and C group oftumours. On the
other hand, in oat cell carcinomas Lennox et al. (1968) found the same survival
rate in tumours involving the visceral pleura and the chest wall. These dis-
crepancies maypartly be due to the different criteria inclassifying tumours as well
as to the different incidence of pathological factors in the various series. One
must consider that the involvement of some structures isprobably moredangerous
thantheinvolvementofotherstructures. BerghandScherste'n(1965)showedthat
the perinodal growth (i.e. the invasion of mediastinal soft tissues) in cases with
lymph node metastasis bore very badly on prognosis. On the other hand,
extendedresection for tumourslocallyinvolving the chestwallhas been stressedby
some surgeons as very valuable for cure, when lymph node metastasis is absent
(Grillo et al., 1966; Ramsey and Clifton, 1968). In the present series 37 out of
45 patients included in P3 category had a 5 year follow-up; of 5 survivors, 4 had
been included in P3 category as the tumours had involved the thoracic wall;
none hadlymph node metastasis. Moreover, Bennet et al. (1969) pointed out that
as far as pleural invasion was concerned, only pleura implants or permeation of
subpleural lymphatics were adverse factors in prognosis. So the distinction
between P2 and P3 tumours whichproved very useful inreporting thepathological
features oflung tumours, seems to be oflittle predictive value in survival.
P4 tumours had a very poor prognosis; no patient with multiple tumours
survived up to 3 years and only 1 out of 26 survived for 2 years. It has been
postulated (Campobasso et al., 1970) that the reason why these tumours have
such a poor prognosis is that in these cases 1 neoplastic mass is the primary lung
tumour and the other mass or masses are distant lung metastases of the primary
lung tumour through the blood stream.
Nodal involvement has been regarded as one of the most important factors
in survival. The data of the present series are in agreement with those of other
authors. The presence oflymph node metastasis affectedmarkedly thepredictive
value of the other factors, except for the P4 category, in which distant metastasis
were probably present, and for P2 large tumours, in which size accounted for the
poorprognosis (TableVll). In any case, inN+ tumours there was nostatistically
significant difference in survival at 5 years amongst the 4 P categories (Fig. lb).
Moreover, nodalinvolvementclearly affectedthepredictivevalue oftumoursize, as
the survivalexperience ofsmall tumours wassignificantly better than that oflarge
ones provided lymph node metastasis was absent (Table VI).
The size ofthe tumour showed no relation to the incidence ofnodal metastasis
(Table 11). As has been pointed out elsewhere (Campobasso and Berrino 1970),
this makes it difficult to regard small tumours as early lung tumours as some
authors do (Hattori et al., 1965; Nagaishi and Okada, 1968). Thereis no exhaus-
tive mentionin the literatureoftherelationshipbetweensizeandnodalinvolvement
in lung tumours, andgenerally the value of tumour size has not been evaluated in
relation to lymph node metastasis. This may well explain why the predictive
value of tumour size has been reported with contradictory results. O'Connor677 FACTORS IN SURVIVAL OF LUNG TUMOURS
et al. (1963), Nagaishi and Okada (1968) and Jackman et al. (1969) regarded small
tumours as candidates for surgery and cure. Hukill and Stern (1962) denied
that size had apredictive value 'in prognosis. Bennet et al. (1969) found that size
had only little value mainly because
" small size does not necessarily denote a
biologically early lesion "; 3 out of 7 of their small tumours had positive lymph
nodes at the time ofresection. Though the author has notfullygot to the bottom
ofthispoint, it is clearfrom Table 6 ofthe recent paperby Slack (1970) that 5 years
survival rates decreased significantly with the increase of tumour size only when
nodal involvement was absent. In the present series tumours up to 4 cm. in
diameter as a whole had a much better prognosis than tumours larger than 4 cm.
(Table V) possibly because the incidence of nodal involvement in the total series
was rather slow. It is clear, however, that whenlymph node metastasis ispresent
at the time of resection, tumour size does not bear significantly on prognosis of
lung tumours.
TABLE VIII.-PathologicalStage-grouping ofLung Tumours
Survival rate at
A
r 1
2 years 3 years 6 years
66-1±12 59-0±13 55-1±13
55-7±10 46-1±10 31-1±9
22-8±6 18-8±5 13-7±5
3
-8±8
Size
(cm.)
< 4
> 4
< 4
<4
> 4
> 4
any size
any size
any size
Other
factors Stage No. p
I 59 Pi
Pi
II 106 P2
P3
P2
P3
in 214 Pi
P2
P3
N
N-
N-
N-
N-
N-
N-
N+
N+
N+
I
IV 26 P4 any size N distant
N+ metastasis (?)
The outcome ofthispresentinvestigation hassuggested that localextent, nodal
involvement and size are pathological factors of predictive value in prognosis of
lung tumours. However, they should not be taken into account one at a time.
Their predictive value, indeed, is much more meaningful when these factors are
correlated with each other, as the predictive value of one factor may be cancelled
by the association with anotherfactor. This has beenclearlydemonstrated, in the
present series, for the tumour size. Correlating these factors with each other in
evaluating their influence on survival, is imperative, therefore, and may be useful
for a stage-grouping. On the ground of their significance and relationship in the
present series, the following pathological stage-grouping oflung tumours may be
tentativelysuggested (TableVIII):
Stage I: N- tumours confined to the lung (PI), up to 4 cm. in diameter.
Stage IT: N- tumours confined to the lung (PI) but larger than 4 cm. and
N- tumoursspread to contiguous or neighbouring structures (P2
and P3), up to 4 cm. in diameter.
Stage III: N- tumoursspread to contiguous orneighbouring structures (P2,
P3) larger than 4 cm.; N+ tumours of any size, confined to the
lung or spread to contiguous or neighbouring structures (PI, P2,
P3).678 P. BERRINO, M. MUSSO AND 0. CAMPOBASSO
Stage IV: N- or N+ multiple tumours (P4) possibly to be regarded as
tumours with distant metastasis.
Tumours included in stage 4-corresponding to P4 category-had a very poor
prognosis. The difference in survival among the other 3 stages was statistically
significant at anyinterval, except between Stage I and Stage II at 2 and 3 years.
It is clearly understood, however, that as experience accumulates the need for
regrouping may become necessary. Moreover, it should be ascertained whether
or not this stage-grouping is valuable for tumours localized in different lobes or
for different histological types. This will be discussed in a paper to follow.
The authors are much indebted to Dr. A. Piazza and Mr. A. Berrino for their
activehelp in the statistical evaluation ofdata on survival.
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